Home LiteratureArticle Details
PMID: 58203 Published · ppublish English Comparative Study Journal Article Research Support, U.S. Gov't, P.H.S.

Inhibition of lymphocyte blastogenesis by plasma of patients with minimal-change nephrotic syndrome.

Lancet (London, England) ·Vol. 1 ·No. 7970 ·1976-05-29 ·Pages 1160-2

Moorthy AV, Zimmerman SW, Burkholder PM

Abstract

Plasma from 7 patients with minimal-change nephrotic syndrome (M.C.N.S.) (lipoid nephrosis) confirmed by renal biopsy inhibited the blastogenic response of lymphocytes to the mitogen phytohaemagglutinin (P.H.A.) and to allogeneic lymphocytes in mixed lymphocyte culture. Plasma from 14 patients with nephrotic syndrome due to other glomerular diseases did not have this effect. 5 of the 7 patients with M.C.N.S. achieved remission; 4 with prednisone and 1 spontaneously. While in remission, plasma from these 5 patients no longer inhibited the response of lymphocytes to P.H.A. These findings suggest a pathogenic relation between M.C.N.S. and cell-mediated immunity.

MeSH Terms
Adolescent Adult Aged Female Humans Immunity, Cellular Kidney Diseases/immunology Kidney Function Tests Lectins/pharmacology Lymphocyte Activation Lymphocyte Culture Test, Mixed Lymphocytes/immunology Male Middle Aged Nephrosis, Lipoid/drug therapy,etiology,immunology Nephrotic Syndrome/etiology,immunology Plasma/immunology Prednisone/therapeutic use Remission, Spontaneous
Chemicals
Lectins Prednisone
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Moorthy A V
Zimmerman S W
Burkholder P M
Article Info
Journal
Lancet (London, England)
Abbr.
Lancet
ISSN
0140-6736
Published
1976-05-29
Pages
1160-2
Language
English
Region
England
NLM ID
2985213R
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]